Literature DB >> 2831953

Carbanicotinamide adenine dinucleotide: synthesis and enzymological properties of a carbocyclic analogue of oxidized nicotinamide adenine dinucleotide.

J T Slama1, A M Simmons.   

Abstract

The dinucleotide carbanicotinamide adenine dinucleotide (carba-NAD), in which a 2,3-dihydroxycyclopentane ring replaces the beta-D-ribonucleotide ring of the nicotinamide ribonucleoside moiety of NAD, has been synthesized and characterized enzymologically. The synthesis begins with the known 1-aminoribose analogue (+/-)-4 beta-amino-2 alpha,3 alpha-dihydroxy-1 beta-cyclopentanemethanol. The pyridinium ring is first introduced and the resultant nucleoside analogue specifically 5'-phosphorylated. Coupling the racemic carbanicotinamide 5'-mononucleotide with adenosine 5'-monophosphate produces two diastereomeric carba-NAD analogues which are chromatographically separable. Only one diastereomer is a substrate for alcohol dehydrogenase and on this basis is assigned a configuration analogous to D-ribose. The reduced dinucleotide carba-NADH was characterized by fluorescence spectroscopy and found to adopt a "stacked" conformation similar to that of NADH. The analogue is reduced by both yeast and horse liver alcohol dehydrogenase with Km and Vmax values for the analogue close to those observed for NAD. Carba-NAD is resistant to cleavage by NAD glycohydrolase, and the analogue has been demonstrated to noncovalently inhibit the soluble NAD glycohydrolase from Bungarus fasciatus venom at low concentrations (less than or equal to 100 microM).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2831953     DOI: 10.1021/bi00401a028

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Structural basis for nicotinamide inhibition and base exchange in Sir2 enzymes.

Authors:  Brandi D Sanders; Kehao Zhao; James T Slama; Ronen Marmorstein
Journal:  Mol Cell       Date:  2007-02-09       Impact factor: 17.970

2.  Design, synthesis and biological characterization of novel inhibitors of CD38.

Authors:  Min Dong; Yuan-Qi Si; Shuang-Yong Sun; Xiao-Ping Pu; Zhen-Jun Yang; Liang-Ren Zhang; Li-He Zhang; Fung Ping Leung; Connie Mo Ching Lam; Anna Ka Yee Kwong; Jianbo Yue; Yeyun Zhou; Irina A Kriksunov; Quan Hao; Hon Cheung Lee
Journal:  Org Biomol Chem       Date:  2011-03-23       Impact factor: 3.876

3.  Inhibition of the intrinsic NAD+ glycohydrolase activity of CD38 by carbocyclic NAD analogues.

Authors:  K A Wall; M Klis; J Kornet; D Coyle; J C Amé; M K Jacobson; J T Slama
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

Review 4.  NAD hydrolysis: chemical and enzymatic mechanisms.

Authors:  N J Oppenheimer
Journal:  Mol Cell Biochem       Date:  1994-09       Impact factor: 3.396

Review 5.  The Pharmacology of CD38/NADase: An Emerging Target in Cancer and Diseases of Aging.

Authors:  Eduardo N Chini; Claudia C S Chini; Jair Machado Espindola Netto; Guilherme C de Oliveira; Wim van Schooten
Journal:  Trends Pharmacol Sci       Date:  2018-02-23       Impact factor: 14.819

6.  carba Nicotinamide Adenine Dinucleotide Phosphate: Robust Cofactor for Redox Biocatalysis.

Authors:  Ioannis Zachos; Manuel Döring; Georg Tafertshofer; Robert C Simon; Volker Sieber
Journal:  Angew Chem Int Ed Engl       Date:  2021-05-10       Impact factor: 15.336

Review 7.  The Multi-faceted Ecto-enzyme CD38: Roles in Immunomodulation, Cancer, Aging, and Metabolic Diseases.

Authors:  Kelly A Hogan; Claudia C S Chini; Eduardo N Chini
Journal:  Front Immunol       Date:  2019-05-31       Impact factor: 8.786

8.  Synthesis of Stable NAD+ Mimics as Inhibitors for the Legionella pneumophila Phosphoribosyl Ubiquitylating Enzyme SdeC.

Authors:  Jerre M Madern; Robbert Q Kim; Mohit Misra; Ivan Dikic; Yong Zhang; Huib Ovaa; Jeroen D C Codée; Dmitri V Filippov; Gerbrand J van der Heden van Noort
Journal:  Chembiochem       Date:  2020-06-16       Impact factor: 3.164

Review 9.  NAD Analogs in Aid of Chemical Biology and Medicinal Chemistry.

Authors:  Anais Depaix; Joanna Kowalska
Journal:  Molecules       Date:  2019-11-19       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.